Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.
NCT ID: NCT03102970
Last Updated: 2018-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2015-12-31
2018-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Chronic pain is common in patients with Chronic Obstructive Pulmonary Disease (COPD). The pain intensity may increase during acute episodes of exacerbations. This study is aimed to compare pain intensity during exacerbation and stable phase of patients with chronic obstructive pulmonary disease (COPD).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Severity and Prognosis in Elderly Patients With COPD and Complex Chronic Comorbidities
NCT01893918
Abnormal Pain Processing in COPD Patients
NCT04319523
Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
NCT03014609
Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD
NCT06826560
Protocol Chronic Obstructive Pulmonary Disease
NCT00404430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* smoking at least ≥ 10 pack years
* previous FEV / FVC \<0.70 post bronchodilator
* admitted for exacerbations (GOLD definition)
Exclusion Criteria
* Patient with chronic pain of neoplastic origin or severe trauma (fracture , dislocation or severe pain) within 15 days before the date of inclusion
* Patient with no social security insurance , with restricted liberty or under legal protection
* Pregnant woman parturient or nursing
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maxime MAIGNAN
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Grenoble
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emergency department of Hôpital du Sacré Coeur de Montréal
Montreal, , Canada
Emergency Department of university hospital
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DR-2016-269
Identifier Type: OTHER
Identifier Source: secondary_id
38RC15.324
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.